Rosetta Genomics (ROSG) Issues Positive Update on MicroRNA-Based Assay for Thyroid Reoplasia Diagnosis
Tweet Send to a Friend
Rosetta Genomics (NASDAQ: ROSG) provides an update on the development of its microRNA-based assay for the differential diagnosis of thyroid ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
